Curaleaf Holdings (CURLF) Long-Term Investments (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Long-Term Investments of $263000.0 for Q4 2025, down 98.24% year-on-year from $15.0 million in Q4 2024, and down 98.24% on a QoQ basis from $15.0 million in Q4 2024.
Curaleaf Holdings (CURLF) Long-Term Investments (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Long-Term Investments for 7 consecutive years, with $263000.0 the latest figure, recorded in Q4 2025.
- Quarterly Long-Term Investments fell 98.24% year-over-year to $263000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $263000.0 (down 98.24% YoY) and the FY2025 annual result came in at $263000.0, down 98.24% from the prior year.
- Long-Term Investments retreated to $263000.0 in Q4 2025 per CURLF's latest filing, from $15.0 million in the prior quarter.
- Over the last five years, Long-Term Investments for CURLF reached as high as $4.1 billion in Q1 2022 and fell as low as $263000.0 in Q4 2025.
- A 5-year average of $282.5 million and a median of $7.4 million in 2021 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments soared 25164.39% — and 2025, when it slumped 98.24%.
- Year by year, Long-Term Investments stood at $4.4 million in 2021, then sank by 36.45% to $2.8 million in 2022, then soared by 438.01% to $15.0 million in 2023, then retreated by 0.44% to $15.0 million in 2024, then sank by 98.24% to $263000.0 in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $263000.0, $15.0 million, and $17.1 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 263,000.00 |
| Dec 31, 2024 | 14.98 Mn |
| Sep 30, 2024 | 17.14 Mn |
| Jun 30, 2024 | 13.93 Mn |
| Dec 31, 2023 | 15.05 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | 3.65 Mn |
| Mar 31, 2022 | 4.11 Bn |
| Dec 31, 2021 | 4.40 Mn |
| Sep 30, 2021 | 7.37 Mn |
| Jun 30, 2021 | 23.49 Mn |
| Mar 31, 2021 | 16.26 Mn |
| Dec 31, 2020 | 16.26 Mn |
| Sep 30, 2020 | 62.81 Mn |
| Dec 31, 2019 | 51.21 Mn |